Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8215 items from SEC EDGAR · filings · clear filters
- 8-K - Sunshine Biopharma Inc. (0001402328) (Filer)
Automated noteSunshine Biopharma Inc. filed a Form 8-K with the SEC on September 11, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001683168-26-007090, 234 KB).
- 8-K - Toppoint Holdings Inc. (0001960847) (Filer)
Automated noteToppoint Holdings Inc. filed a Form 8-K on September 11, 2026, reporting a submission of matters to a vote of security holders and disclosing other events.
- 8-K - DEERE JOHN CAPITAL CORP (0000027673) (Filer)
Automated noteDeere John Capital Corp filed a Form 8-K on September 11, 2026 (accession 0001104659-26-107111), including Item 9.01 financial statements and related exhibits.
- 8-K/A - CUMBERLAND PHARMACEUTICALS INC (0001087294) (Filer)
Automated noteCumberland Pharmaceuticals Inc. filed an amended Form 8-K on September 11, 2026 (Accession No. 0001087294-26-000068), including Item 5.07 that details the submission of matters to a vote of its security holders.
- 8-K - DAILY JOURNAL CORP (0000783412) (Filer)
Automated noteDaily Journal Corp filed a Form 8-K on September 11, 2026, reporting amendments to its articles of incorporation/bylaws, a change in fiscal year, items submitted for security-holder vote, other events, and accompanying financial statements and exhibits.
- 8-K - CENTRUS ENERGY CORP (0001065059) (Filer)
Automated noteCentrus Energy Corp filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Zone Frontier Inc. (0001956741) (Filer)
Automated noteZone Frontier Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and disclosed compensatory arrangements for those officers.
- 8-K - BONK, INC. (0001760903) (Filer)
Automated noteBonk, Inc. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Cardinal Infrastructure Group Inc. (0002079999) (Filer)
Automated noteCardinal Infrastructure Group Inc. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - GridAI Technologies Corp. (0001604191) (Filer)
Automated noteGridAI Technologies Corp. filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - AIB Data Centers Inc. (0002070542) (Filer)
Automated noteAIB Data Centers Inc. filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - Oportun Financial Corp (0001538716) (Filer)
Automated noteOportun Financial Corp filed a Form 8-K on September 11, 2026, reporting director and officer departures, elections, appointments, compensatory arrangements for certain officers, other events, and accompanying financial statements and exhibits.
- 8-K - Rainier Acquisition Corp (0002147219) (Filer)
Automated noteRainier Acquisition Corp filed a Form 8-K on September 11, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001104659-26-107095.
- 8-K - Quetta Acquisition Corp (0001978528) (Filer)
Automated noteQuetta Acquisition Corp filed a Form 8-K with the SEC on September 11, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001829126-26-010050, 252 KB).
- 8-K - AMREP CORP. (0000006207) (Filer)
Automated noteAmrep Corp filed a Form 8-K on September 11, 2026, reporting its results of operations and financial condition, changes to directors and officers with related compensation arrangements, matters submitted for a shareholder vote, and accompanying financial statements.
- 8-K - Peraso Inc. (0000890394) (Filer)
Automated notePeraso Inc. filed a Form 8-K on September 11, 2026, reporting director and officer departures, appointments, compensatory arrangements, shareholder voting matters, and accompanying financial statements and exhibits.
- 8-K - Greenland Mines Ltd (0001907223) (Filer)
Automated noteGreenland Mines Ltd filed a Form 8-K on September 11, 2026, reporting departures, elections, appointments and compensatory arrangements for certain officers, and providing its financial statements and related exhibits.
- 8-K - Q/C TECHNOLOGIES, INC. (0001321834) (Filer)
Automated noteQ/C Technologies, Inc. filed a Form 8-K reporting the termination of a material definitive agreement, the departure and appointment of certain directors and officers with related compensation arrangements, and the inclusion of financial statements and exhibits.
- 8-K - Dare Bioscience, Inc. (0001401914) (Filer)
Automated noteDare Bioscience, Inc. filed a Form 8-K on September 11, 2026 reporting amendments to its articles of incorporation or bylaws and a change to its fiscal year.
- 8-K - SILVER BOW MINING CORP. (0002067674) (Filer)
Automated noteSilver Bow Mining Corp filed a Form 8-K on September 11, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Business First Bancshares, Inc. (0001624322) (Filer)
Automated noteBusiness First Bancshares, Inc. filed a Form 8-K reporting the departure of certain directors or officers, the election or appointment of new directors or officers, and related compensatory arrangements for those officers.
- 8-K - P3 Health Partners Inc. (0001832511) (Filer)
Automated noteP3 Health Partners Inc. filed a Form 8-K reporting entry into a material definitive agreement, unregistered sales of equity securities, and amendments to its articles of incorporation/bylaws, including a change in its fiscal year.
- 8-K - Gen Digital Inc. (0000849399) (Filer)
Automated noteGen Digital Inc. filed a Form 8-K on September 11, 2026 (Accession No. 0000849399-26-000053) reporting that it has submitted certain matters to a vote of its security holders, as required by Item 5.07.
- 8-K - CORNING INC /NY (0000024741) (Filer)
Automated noteCorning Inc. filed a Form 8-K on September 11, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Korsana Biosciences, Inc. (0001755237) (Filer)
Automated noteKorsana Biosciences filed a Form 8-K reporting entry into a material definitive agreement, completion of an acquisition, operational results, unregistered equity sales, modifications to security-holder rights, changes in control, and director/officer departures and appointments.
- 8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
Automated noteLifeStance Health Group, Inc. filed a Form 8-K with the SEC on September 11, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - ESSEX PROPERTY TRUST, INC. (0000920522) (Filer)
Automated noteEssex Property Trust, Inc. filed a Form 8-K on September 11 2026, disclosing information under Item 7.01 (Regulation FD Disclosure).
- 8-K - ESSEX PORTFOLIO LP (0001053059) (Filer)
Automated noteEssex Portfolio LP filed a Form 8-K on September 11, 2026, providing a Regulation FD Disclosure (Item 7.01) accompanied by a 180 KB document.
- 8-K - CELESTICA INC (0001030894) (Filer)
Automated noteCelestica Inc. filed a Form 8-K reporting departures and appointments of directors and certain officers, related compensation arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - Artiva Biotherapeutics, Inc. (0001817241) (Filer)
Automated noteArtiva Biotherapeutics filed an 8-K on September 11, 2026, reporting director and officer departures, elections, appointments, related compensation arrangements, shareholder-vote matters, and accompanying financial statements and exhibits.